BGF World Healthscience A2 CNH H/ LU1254117382 /
| NAV7/1/2022 | Chg.+0.6900 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 178.8500CNH | +0.39% | reinvestment | Equity Worldwide | BlackRock (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | - | - | -5.99 | -8.48 | 6.86 | -0.02 | 1.62 | - |
| 2016 | -9.73 | 0.11 | 1.76 | 4.24 | 2.37 | -0.56 | 5.51 | -3.22 | -0.46 | -6.14 | 1.53 | 0.18 | -5.31% |
| 2017 | 2.19 | 7.82 | 0.89 | 2.60 | 1.58 | 3.95 | 0.28 | -0.20 | 1.14 | -0.06 | 2.14 | 0.71 | +25.32% |
| 2018 | 6.39 | -3.76 | -3.40 | 2.39 | 2.09 | 1.52 | 4.21 | 4.06 | 2.73 | -5.97 | 4.53 | -7.34 | +6.49% |
| 2019 | 4.68 | 3.06 | 0.20 | -3.21 | -1.70 | 7.00 | 2.05 | -0.20 | -1.44 | 4.80 | 4.38 | 2.98 | +24.44% |
| 2020 | -0.20 | -8.42 | -2.65 | 11.58 | 3.78 | -1.34 | 6.01 | 1.45 | -1.23 | -4.76 | 8.12 | 3.90 | +15.53% |
| 2021 | 1.88 | -2.46 | 1.58 | 5.04 | 1.16 | 2.58 | 2.07 | 1.88 | -4.13 | 2.37 | -2.20 | 6.48 | +16.94% |
| 2022 | -8.14 | -0.43 | 6.34 | -3.33 | -1.54 | -2.17 | 0.39 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.41% | 19.49% | 15.78% | 17.09% | 15.63% |
| Sharpe ratio | -0.89 | -0.74 | -0.24 | 0.66 | 0.72 |
| Best month | +6.48% | +6.34% | +6.48% | +11.58% | +11.58% |
| Worst month | -8.14% | -8.14% | -8.14% | -8.42% | -8.42% |
| Maximum loss | -15.48% | -15.48% | -15.48% | -26.30% | -26.30% |
| Outperformance | - | - | - | - | - |
All quotes in CNH
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| BGF World Healthscience A2 AUD H | reinvestment | 20.2400 | -6.77% | +25.79% | |
| BGF World Healthscience A2 HKD H | reinvestment | 208.1500 | -6.11% | +30.53% | |
| BGF World Healthscience A2 SGD H | reinvestment | 20.6600 | -6.01% | +28.80% | |
| BGF World Healthscience C2 EUR | reinvestment | 45.1300 | +6.26% | +37.68% | |
| BGF World Healthscience A2 CNH H | reinvestment | 178.8500 | -3.94% | +37.30% | |
| BGF World Healthscience D2 USD | reinvestment | 67.8000 | -5.06% | +34.26% | |
| BGF World Healthscience D2 EUR | reinvestment | 65.1900 | +8.43% | +46.20% | |
| BGF World Healthscience D4 EUR | paying dividend | 15.4600 | -5.04% | +34.26% | |
| BGF World Healthscience X2 USD | reinvestment | 75.8100 | -4.12% | +38.31% | |
| BGF World Healthscience E2 USD | reinvestment | 54.6500 | -6.24% | +29.32% | |
| BGF World Healthscience A4 EUR | paying dividend | 11.0100 | +7.52% | - | |
| BGF World Healthscience A4 USD | paying dividend | 11.4600 | -5.76% | - | |
| BGF World Healthscience A2 EUR H | reinvestment | 13.6900 | -7.12% | +24.68% | |
| BGF World Healthscience E2 EUR | reinvestment | 52.5400 | +7.07% | +40.82% | |
| BGF World Healthscience A2 USD | reinvestment | 60.6900 | -5.78% | +31.25% | |
| BGF World Healthscience A2 EUR | reinvestment | 58.3500 | +7.60% | +42.94% |
Performance
| YTD | -9.08% | ||
|---|---|---|---|
| 6 Months | -7.42% | ||
| 1 Year | -3.94% | ||
| 3 Years | +37.30% | ||
| 5 Years | +69.38% | ||
| Since start | +78.85% | ||
| Year | |||
| 2021 | +16.94% | ||
| 2020 | +15.53% | ||
| 2019 | +24.44% | ||
| 2018 | +6.49% | ||
| 2017 | +25.32% | ||
| 2016 | -5.31% | ||